SEC Filings
ARK Reports 6.42% GeneDx Stake Without Seeking To Influence Company Control
The investment manager's report covered 1,913,123 common shares held as of September 30.
GeneDx (WGS) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
SEC Filings
The investment manager's report covered 1,913,123 common shares held as of September 30.
Earnings
Genome collections improved, but management lowered volume expectations and put annual revenue at the bottom of its guidance range.
Earnings
Third-quarter sales rose 5%, while adjusted earnings fell to $8.6 million from $16.1 million a year earlier.
SEC Filings
The investment manager reported 1,560,247 shares, with sole voting authority over 1,418,435.